Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Fluspirilene is a dopamine D2 and D3 receptor antagonist (Kis = 1.5 and 1.1 nM, respectively).1 It is selective for dopamine D2 and D3 receptors over dopamine D1, α1- and α2-adrenergic, H1 histamine, and sigma-1 (σ1) receptors (Kis = 450, 102, >5,000, 540, and 150 nM, respectively), muscarinic acetylcholine receptors (mAChRs; Ki = >5,000 nM), and the serotonin (5-HT) receptor subtypes 5-HT1A, 5-HT1B, 5-HT2C, and 5-HT3 (Kis = 110, >5,000, 1,830, and >5,000 nM, respectively). Fluspirilene is also a noncompetitive inhibitor of L-type calcium (Cav1) channels with an IC50 value of 30 nM.2 It inhibits apomorphine-induced vomiting in dogs (ED50 = 0.011 mg/kg).3 Formulations containing fluspirilene have been used in the treatment of schizophrenia.
WARNING This product is not for human or veterinary use.
1. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology (Berl) 124(1-2), 57-73 (1996).
2. Selective antagonism of calcium channel activators by fluspirilene. Br. J. Pharmacol. 100(2), 211-216 (1990).
3. Pharmacology of fluspirilene (R 6218) [8-